What diseases should you be wary of if you have a headache after taking dasatinib?
Dasatinib (Dasatinib), as a second-generation tyrosine kinase inhibitor (TKI), is widely used to treat patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). During the treatment process, some patients reported headache symptoms. Although this phenomenon is not uncommon among TKI drugs, clinicians and patients still need to be alert to the potential pathological changes or drug-related risks it may reflect. The occurrence of headache may be a short-lived, mild adverse reaction, or it may indicate a more serious complication, which should be highly concerned especially if it occurs for a long time or occurs repeatedly.

First, headaches experienced after taking dasatinib may sometimes be related to neurological side effects caused by the drug. Although dasatinib mainly acts on the blood system, it also has a certain ability to penetrate the central nervous system. Especially in the case of blood-brain barrier insufficiency, the increased concentration of the drug in the cerebrospinal fluid may irritate the meninges and cause headaches. Additionally, headaches can also be the result of fluctuations in blood pressure. Dasatinib can cause hypertension or unstable blood pressure in some people. This change may indirectly lead to an increase in intracranial pressure and trigger throbbing or tightening headaches. Therefore, when headache occurs, it is recommended to monitor blood pressure levels simultaneously to determine whether there is a drug-induced hypertensive state.
Second, headaches may also be associated with more serious side effects, such as pleural effusion. One of the more common adverse reactions of dasatinib is pleural effusion, which may affect lung function, cause hypoxemia, and indirectly cause headaches. Such conditions are often accompanied by symptoms such as shortness of breath, chest tightness, and decreased physical strength. If headache occurs at the same time as these symptoms, it should be highly suspected that it is caused by a systemic reaction, and it is recommended to conduct imaging examinations immediately to confirm the diagnosis.
Reference materials:https://go.drugbank.com/drugs/DB01254
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)